logo
episode-header-image
Sep 2011
6m 56s

Aiming for a HIV vaccine

OXFORD UNIVERSITY
About this episode
Professor Sir Andrew McMichael tells us about recent developments in the search for a vaccine against HIV. As HIV infection continues to spread, particularly in developing countries there is an urgent need for a vaccine. After investigating the immune response to flu virus, Professor Sir Andrew McMichael turned his attention to HIV. Professor McMichael's cur ... Show More
Up next
Dec 2012
Can we eradicate HIV?
Dr John Frater talks about his research into finding a cure for HIV. It is increasingly apparent that highly active antiretroviral therapy (HAART) may not be the long-term solution to the management of HIV infection, and that other avenues need to be explored. As a result of vari ... Show More
6m 19s
Jan 2012
How can we live with HIV?
Dr Lucy Dorrell tells us how our immune system controls HIV and how we can live with this virus. There are currently around 91,000 people in the UK living with HIV/AIDS. HIV is a challenging target for a vaccine because it can mutate its genetic makeup. Dr Lucy Dorrell aims to de ... Show More
3m 39s
Feb 2012
HIV and children in Africa
Professor Sarah Rowland-Jones tells us about her work on HIV with children in Africa. HIV behaves very differently in children: while most adults are able to control the virus after infection, children often struggle to do so, resulting in an extremely high mortality rate. Profes ... Show More
6m 7s
Recommended Episodes
Nov 2021
HIV heute: Von verpassten Chancen und Hoffnung auf Heilung
Experteninterview mit Dr. Hartmut Stocker (Infektiologe) und Henrieke Prins (Infektiologin) Vor 40 Jahren erschien die erste wissenschaftliche Publikation, die eine “neue erworbene Immundefizienz” beschrieb. Zwei Jahre später identifizierte man die Ursache: HIV. Noch heute stellt ... Show More
57m 56s
Nov 2022
What changes can the new HIV/AIDS drug bring?
For years the fight against HIV/AIDS was fought with antiretroviral drugs. But in October the Medicines Control Authority of Zimbabwe announced that it had approved the use of a new medicine against HIV/AIDS. CAB-LA is long-acting injectable cabotegravir with the aim of preventin ... Show More
15m 34s
Jun 2019
HIV
In this episode I cover HIV. If you want to follow along with written notes on HIV go to https://zerotofinals.com/medicine/infectiousdisease/hiv/ or the infectious diseases section in the Zero to Finals medicine book. This episode covers the definitions, transmission, associated ... Show More
14m 26s
Jul 2022
HIV and COVID-19 – What We’ve Learned
How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinic ... Show More
25m 55s
Apr 2021
HIV/AIDS and Stigma (with Peter Staley, Jonathan Van Ness & Dr. Oni Blackstock)
When HIV was first identified in the early 1980s, it was a public health crisis mired in urgent scientific questions: How was it transmitted? What were the symptoms? Could it be treated? But alongside that, and equally challenging to public health, was the stigma attached to the ... Show More
54m 23s
Feb 2024
RSV and Vaccine Hesitancy
Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messag ... Show More
34m 59s
Jul 2023
CME-Kurs HIV-Infektion
Interview mit Dr. Hartmut Stocker und Henrieke Prins, MD, PhD (FÄ Infektiologie) HIV: Zwischen verpassten Diagnosen und Lichtblicken in der Forschung. Inhaltsverzeichnis: 00:00 Intro 02:25 Aktuelle Zahlen und Ziele 07:38 Pathophysiologie 09:20 Impfung: HIV ist nicht Corona 12:48 ... Show More
58m 12s
Jun 2020
The case to infect volunteers with COVID-19 to accelerate vaccine testing | Nir Eyal
Conventional vaccine testing is a slow, years-long process. As thousands of people continue to die each day from COVID-19, bioethicist Nir Eyal proposes a radical idea that could dramatically accelerate the vaccine development timeline: "human challenge trials," in which scientis ... Show More
16m 23s
Feb 2022
What does a virology and immunology professor do when a new virus hits?
When the COVID-19 virus hit two years ago, AUB Associate Professor of pathology, virology and immunology Hassan Zaraket spiked to a new level of action. He adjusted his lab research -- on the genetic makeup of viruses and their spread, mutations, and vaccine responses -- to devel ... Show More
23m 24s